









Markets
/
Stocks
/
nasdaq-rkda
/

Arcadia Biosciences Inc

RKDA

1.800USD

+0.040+2.27%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

2.46MMarket Cap

LossP/E TTM



Arcadia Biosciences Inc

1.800

+0.040+2.27%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Arcadia Biosciences Inc

Currency: USD Updated: 2026-02-06

Key Insights

Arcadia Biosciences Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 69 out of 96 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Arcadia Biosciences Inc's Score

Industry at a Glance

Industry Ranking

69 / 96

Overall Ranking

443 / 4521

Industry

Food & Tobacco

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Arcadia Biosciences Inc Highlights

StrengthsRisks

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Growing

The company is in a growing phase, with the latest annual income totaling USD 5.04M.

Fairly Valued

The company’s latest PE is -0.48, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 64.93K shares, decreasing 77.58% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 14.04K shares of this stock.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

12.000

Target Price

+207.69%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Arcadia Biosciences Inc is 6.36, ranking 73 out of 96 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.30M, representing a year-over-year decrease of 15.29%, while its net profit experienced a year-over-year decrease of 153.10%.

Score

Industry at a Glance

Previous score

6.36

Change



Financials

8.50

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

5.91

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.20

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.19

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.99

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Arcadia Biosciences Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Arcadia Biosciences Inc is 7.77, ranking 53 out of 96 in the Food & Tobacco industry. Its current P/E ratio is -0.48, which is -75.96% below the recent high of -0.12 and -596.78% above the recent low of -3.38.

Score

Industry at a Glance

Previous score

7.77

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 69/96

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Arcadia Biosciences Inc. The Food & Tobacco industry's average is 7.41. The average price target is 12.00, with a high of 12.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

12.000

Target Price

+207.69%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Arcadia Biosciences Inc

RKDA

Mondelez International Inc

MDLZ

Hershey Co

HSY

Kraft Heinz Co

KHC

General Mills Inc

GIS

International Flavors & Fragrances Inc

IFF

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Arcadia Biosciences Inc is 6.38, ranking 76 out of 96 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 2.46 and the support level at 1.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.26

Change

0.12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.017

Sell

RSI(14)

28.149

Sell

STOCH(KDJ)(9,3,3)

7.111

Oversold

ATR(14)

0.121

Low Volatility

CCI(14)

-135.747

Sell

Williams %R

87.879

Oversold

TRIX(12,20)

-1.380

Sell

StochRSI(14)

40.884

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.888

Sell

MA10

2.027

Sell

MA20

2.202

Sell

MA50

2.807

Sell

MA100

3.307

Sell

MA200

3.770

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Arcadia Biosciences Inc is 3.00, ranking 57 out of 96 in the Food & Tobacco industry. The latest institutional shareholding proportion is 2.98%, representing a quarter-over-quarter decrease of 30.99%. The largest institutional shareholder is The Vanguard, holding a total of 14.04K shares, representing 0.64% of shares outstanding, with 37.35% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

14.04K

Geode Capital Management, L.L.C.

13.00K

+1.61%

Mariner Wealth Advisors

12.26K

-15.42%

State Street Investment Management (US)

12.15K

DRW Securities, LLC

10.03K

Jacot (Stanley Jr)

5.00K

Schaefer (Thomas J.)

2.82K

Kawakami (Mark)

2.68K

Tower Research Capital LLC

1.69K

-11.91%

Morgan Stanley & Co. LLC

606.00

-22.80%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Tobacco domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Arcadia Biosciences Inc is 1.33, ranking 87 out of 96 in the Food & Tobacco industry. The company's beta value is 0.59. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.